165 related articles for article (PubMed ID: 33998473)
1. Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Iglesias P; Santacruz E; García-Sancho P; Marengo AP; Guerrero-Pérez F; Pian H; Fajardo C; Villabona C; Díez JJ
Rev Clin Esp (Barc); 2021 Jan; 221(1):18-25. PubMed ID: 33998473
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Iglesias P; Santacruz E; García-Sancho P; Marengo AP; Guerrero-Pérez F; Pian H; Fajardo C; Villabona C; Díez JJ
Rev Clin Esp; 2021 Jan; 221(1):18-25. PubMed ID: 32646754
[TBL] [Abstract][Full Text] [Related]
3. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
4. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
5. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
7. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
[TBL] [Abstract][Full Text] [Related]
8. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
9. Clinical, Biochemical, Tumoural and Mutation Profile of VHL- and MEN2A-Associated Pheochromocytoma: A Comparative Study.
Dhanda M; Agarwal A; Mandal K; Gupta S; Sabaretnam M; Chand G; Mishra A; Agarwal G; Mishra SK
World J Surg; 2022 Mar; 46(3):591-599. PubMed ID: 34859295
[TBL] [Abstract][Full Text] [Related]
10. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
11. Adrenalectomy for familial pheochromocytoma in the laparoscopic era.
Brunt LM; Lairmore TC; Doherty GM; Quasebarth MA; DeBenedetti M; Moley JF
Ann Surg; 2002 May; 235(5):713-20; discussion 720-1. PubMed ID: 11981218
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
13. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
14. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.
Eisenhofer G; Timmers HJ; Lenders JW; Bornstein SR; Tiebel O; Mannelli M; King KS; Vocke CD; Linehan WM; Bratslavsky G; Pacak K
J Clin Endocrinol Metab; 2011 Feb; 96(2):375-84. PubMed ID: 21147885
[TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma in MEN 2A syndrome. Study of 54 patients.
Rodriguez JM; Balsalobre M; Ponce JL; Ríos A; Torregrosa NM; Tebar J; Parrilla P
World J Surg; 2008 Nov; 32(11):2520-6. PubMed ID: 18795243
[TBL] [Abstract][Full Text] [Related]
16. [Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytomas].
Plouin PF; Gimenez-Roqueplo AP; La Batide Alanore A; Salenave S; Duclos JM
Rev Med Interne; 2000 Dec; 21(12):1075-85. PubMed ID: 11191675
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Breza J; Breza J
Bratisl Lek Listy; 2018; 119(2):120-125. PubMed ID: 29455549
[TBL] [Abstract][Full Text] [Related]
19. Alpha blockade in preoperative preparation of patients with pheochromocytomas.
Kocak S; Aydintug S; Canakci N
Int Surg; 2002; 87(3):191-4. PubMed ID: 12403097
[TBL] [Abstract][Full Text] [Related]
20. Alpha blockade with doxazosin in pheochromocytoma--report of three cases.
Carvalho MR; Dias T; Rodrigues A; Machado AP; Esteves R; do Carmo I
Rev Port Cardiol; 2010 Feb; 29(2):299-308. PubMed ID: 20545254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]